Good Laboratory Practice

  • Search by category

  • Show all

Good Laboratory Practice

April 7, 2025
 - Tim Hardman
[wpdreams_ajaxsearchlite]

About the author

Tim Hardman

Managing Director
View profile
Dr Tim Hardman is Managing Director of Niche Science & Technology Ltd., a bespoke services CRO based in the UK. He is also Chairman of the Association of Human Pharmacology in the Pharmaceutical Industry, the representative industry body for early for early phase clinical studies in the UK, and President of the sister organisation the European Federation for Exploratory Medicines Development. Dr Hardman is a keen scientist and an occasional commentator on all aspects of medicine, business and the process of drug development.

Good Laboratory Practice

This discussion around the document, titled "Staying Fab in the Lab: An Insider’s Insight into Good Laboratory Practice," explains the principles and importance of Good Laboratory Practice (GLP), a quality system ensuring the integrity and reliability of nonclinical animal studies.

It highlights that GLP is crucial for ethical animal treatment and generating dependable safety data for various products like pharmaceuticals and cosmetics.

The text outlines the historical context of GLP development, driven by past issues of fraudulent lab practices, and details key aspects such as responsibilities, reporting, and equipment standards.

While not all early-stage research requires GLP, understanding its application is essential for anyone involved in nonclinical research, including medical writers who assess study quality.

April 7, 2025
 - Tim Hardman

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility